Sam68 is Overexpressed in Epithelial Ovarian Cancer and Promotes Tumor Cell Proliferation

Abstract

BackgroundEpithelial ovarian cancer (EOC) is the deadliest gynecological malignancy, and evidence is accumulating on how molecular markers may be associated with the origin and process of EOC. Sam68 (Src-associated in mitosis, of 68 kD), is a K homology domain RNA-binding protein that has been investigated as a risk factor in multiple types of tumors. The aim of the present study was to investigate the contribution of the Sam68 gene in the pathogenesis of EOC.Material/MethodsWestern blot assay and real-time quantitative PCR methods were performed to examine Sam68 expression in EOC tissue specimens. The association of Sam68 expression with clinic-pathologic variables of EOC was evaluated. Then gain-of-function and loss-of-function strategies were adopted to examine the regulation of Sam68 on the proliferation of EOC OVCAR-3 cells using CCK-8 and colony forming assays.ResultsSam68 was overexpressed in both mRNA and protein levels in EOC tumor tissue (n=152) in an association with malignant factors of EOC such as International Federation of Gynecology and Obstetrics (FIGO) stage, residual tumor size (cm), histological grade, and lymph node metastasis. In vitro results demonstrated that Sam68 overexpression was upregulated while Sam68 knockdown downregulated the proliferation of EOC OVCAR-3 cells via regulation of cell growth and colony formation.ConclusionsSam68 was overexpressed in EOC tissue in association with such cancer malignant factors of FIGO stage, histological grade, and lymph node metastasis, and also positively regulated the proliferation of EOC cells. Our research suggests that Sam68 might accelerate cell cycle progression, and present as a prognostic marker for EOC.

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features

“…In ACTHomas, our results demonstrated that the altered expression of only two SFs, MAGOH and KHDRBS1, was sufficient to fully discriminate ACTHomas from NPs. These SFs were markedly upregulated in ACTHomas, which is in accordance with the increased expression of KHDRBS1 found in gastric cancer, epithelial ovarian cancer or sacral chordomas, wherein its presence was associated with poor prognosis and aggressive characteristics [65,66]. Likewise, MAGOH has been shown to be differentially expressed in breast cancer, where it served, together with other RNA processing factors, to develop a robust stratification of breast cancer subtypes [67].…”

Alginate Particles with Ovalbumin (OVA) Peptide Can Serve as a Carrier and Adjuvant for Immune Therapy in B16-OVA Cancer Model

“…Similarly, the production of IL-8 and G-CSF cytokines also confirmed that alginate particles can promote cytokine secretion ( Figure 5A, 5B ). These results indicated that alginate particles can serve as an adjuvant to treat tumors, not only for melanomas, but also other tumors such as ovarian cancers, for which several biomarkers have been recently found [ 18 – 23 ]. We only investigated macrophages in this study, but during the immune responses to vaccination, other cells, especially dendritic cells, B cells, and natural killer cells, also have important functions.…”